FindTrial
Sign In

Assessing the combined efficacy of Ruksha Churna Pinda Sweda, Virechana, and Kshara Basti (Yoga Basti) in managing Amavata (Ankylosing Spondylitis): An Open-Label Clinical Study

Evaluation of the combined efficacy of Ruksha Churna Pinda Sweda ,Virechana and Kshara Basti(Yoga Basti)in the management of Amavata(Ankylosing Spondylitis):Single Arm Open Ended Clinical Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075580
Enrollment
27
Registered
2024-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M45- Ankylosing spondylitis

Interventions

None listed

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 yrs. to 60 yrs 2. Chronicity: 1yr to 5 years. 3. Gender: Both 4. . Diagnosed cases of Ankylosing Spondylitis.(upto Grade 2 of sacroiliitis). 5. Socio- economic status: All

Exclusion criteria

Exclusion criteria: 1. Chronicity of more than 5 yrs 2. Severely deformed joints. 3. Cardiac disease, pulmonary tuberculosis, severe lung disease, diabetes and pregnant women. 4. Patients unfit for Snehana, Svedana, Virechana and Basti Karma.

Design outcomes

Primary

MeasureTime frame
Reduction in pain and stiffness.Timepoint: 0th day,7th day,21th day,30th day,60th day,90th day—

Secondary

MeasureTime frame
1.Overall improvement in quality of life. 2. Reduction in inflammation and fatigue. 3.Measurement of changes in Inflammatory markers q-CRP,ESR,INTERLEUKIN-17.Timepoint: 0th day ,90th day—

Countries

India

Contacts

Public ContactDr Prasanth Dharmarajan

All India Institute Of Ayurveda

drprasanthd@gmail.com9895174060

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026